Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alcobra Pharma
Biotech
RNA biotech Arcturus backs onto Nasdaq in Alcobra deal
The deal will give Arcturus a route to public investors at a time when interest in RNA drugs is flying high on the back of Alnylam’s phase 3 success.
Nick Paul Taylor
Sep 28, 2017 9:49am
Alcobra abandons troubled lead drug
Jan 17, 2017 8:36am
FDA full clinical hold throws another wrench into Alcobra’s stuttering R&D machine
Sep 29, 2016 6:16am